Beyond TROP2 NMR: AI & Computational Pathology for IHC-Based Diagnostics
- Describing how QCS delivers human interpretable features beyond Normalized Membrane Ratio (NMR) for biomarker Dx development
- Discussing the future of computational pathology-based IHC diagnostics including the use of controls
- Examining the future of AI in the development of multimodal-based diagnostics